Susquehanna International Group, LLP Clene Inc. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 07, 2024	SELL	$0.28 - $0.53 $11,676 - $22,101	-41,700 Reduced 54.94%	34,200 $14,000
Q4 2023 Feb 14, 2024	SELL	$0.26 - $0.55 $2,782 - $5,885	-10,700 Reduced 12.36%	75,900 $22,000
Q3 2023 Nov 14, 2023	SELL	$0.46 - $0.87 $13,064 - $24,708	-28,400 Reduced 24.7%	86,600 $43,000
Q2 2023 Aug 11, 2023	BUY	$0.78 - $1.22 $15,132 - $23,668	19,400 Added 20.29%	115,000 $101,000
Q1 2023 May 16, 2023	SELL	$0.95 - $1.62 $160,930 - $274,428	-169,400 Reduced 63.92%	95,600 $108,000

Q4 2022 Feb 14, 2023	SELL	$0.92 - $1.11 $648,876 - $782,883	-705,300 Reduced 72.69%	265,000 $265,000
Q3 2022 Nov 14, 2022	BUY	$0.33 - $4.83 $312,609 - $4.58 Million	947,300 Added 4118.7%	970,300 $2.72 Million

7.44M

48.1K

160K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $21M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.